IMPACT-ALS: summary of results from a European survey of people living with ALS

References

• Baxter SK, Baird WO, Thompson S, Bianchi SM, Walters SJ, Lee E, et al. The initiation of non-invasive ventilation for patients with motor neuron disease: patient and carer perceptions of obstacles and outcomes. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:105–10.
   PubMed Web of Science ®Google Scholar
• Simmons Z. Patient-perceived outcomes and quality of life in ALS. Neurotherapeutics 2015;12:394–402.
   PubMed Web of Science ®Google Scholar
• Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531–48.
   PubMed Web of Science ®Google Scholar
• Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? BMJ 2001;322:1240–3.
   PubMed Web of Science ®Google Scholar
• Barclay R, Tate RB. Response shift recalibration and reprioritization in health-related quality of life was identified prospectively in older men with and without stroke. J Clin Epidemiol. 2014;67:500–7.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Zizzi C, Seabury J, Rosero S, Alexandrou D, Wagner E, Weinstein JS, et al. Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): a national, cross-sectional study. eClinicalMedicine 2023;55:101768.
   PubMedGoogle Scholar
• ALS Association. IMPACT ALS – investigation and measuring patient and caregiver trends about ALS. [Internet]. Harvard Dataverse. 2019. Available at: https://dataverse.harvard.edu/dataset.xhtml?persistentId=. Accessed June 6, 2023.
   Google Scholar
• Brizzi KT, Bridges JFP, Yersak J, Balas C, Thakur N, Galvin M, et al. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:355–63.
   PubMed Web of Science ®Google Scholar
• ENCALS – The European Network for the Cure of ALS (ENCALS) [Internet]. ENCALS. Available at: https://www.encals.eu/. Accessed June 6, 2023.
   Google Scholar
• VOP-ALS_FINAL_For-Posting-10-23-19.pdf [Internet]. 2019. Available at: https://www.als.org/sites/default/files/2020-06/VOP-ALS_FINAL_For-Posting-10-23-19.pdf. Accessed June 6, 2023.
   Google Scholar
• Brown CA, Lally C, Kupelian V, Flanders WD. Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants. Neuroepidemiology 2021;55:342–53.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000;55:388–92.
   PubMed Web of Science ®Google Scholar
• Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology 2001;56:442–4.
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 1992;45:743–60.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Thornton EW, Young CA. The patient experience of fatigue in motor neurone disease. Front Psychol. 2013;4:788.
   PubMed Web of Science ®Google Scholar
• Nicholson K, Murphy A, McDonnell E, Shapiro J, Simpson E, Glass J, et al. Improving symptom management for people with amyotrophic lateral sclerosis. Muscle Nerve 2018;57:20–4.
   PubMed Web of Science ®Google Scholar
• McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry. 2009;80:1146–9.
   PubMed Web of Science ®Google Scholar
• Young CA, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, et al. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:317–27.
   PubMed Web of Science ®Google Scholar
• Gibbons C, Pagnini F, Friede T, Young CA. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2018;1:CD011005.
   PubMedGoogle Scholar
• Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 2013;80:409–16.
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet 2004;363:978–88.
   PubMed Web of Science ®Google Scholar
• Induruwa I, Constantinescu CS, Gran B. Fatigue in multiple sclerosis – a brief review. J Neurol Sci. 2012;323:9–15.
   PubMed Web of Science ®Google Scholar
• Hurwitz N, Radakovic R, Boyce E, Peryer G. Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:449–58.
   PubMed Web of Science ®Google Scholar
• Vogt S, Schlichte I, Schreiber S, Wigand B, Debska-Vielhaber G, Heitmann J, et al. A multi-center cohort study on characteristics of pain, its impact and pharmacotherapeutic management in patients with ALS. J Clin Med. [serial online]. 2021;10:4552. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509485/. Accessed June 6, 2023.
   PubMedGoogle Scholar
• Elliott E, Newton J, Rewaj P, Gregory JM, Tomarelli L, Colville S, et al. An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:116–22.
   PubMed Web of Science ®Google Scholar
• Maresca G, Pranio F, Naro A, De Luca R, Maggio MG, Scarcella I, et al. Augmentative and alternative communication improves quality of life in the early stages of amyotrophic lateral sclerosis. Funct Neurol. 2019;34:35–43.
   PubMed Web of Science ®Google Scholar
• Felgoise SH, Zaccheo V, Duff J, Simmons Z. Verbal communication impacts quality of life in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:179–83.
   PubMed Web of Science ®Google Scholar
• Prado LdGR, Bicalho ICS, Vidigal-Lopes M, Prado VdGR, Gomez RS, de Souza LC, et al. Depression and anxiety in a case series of amyotrophic lateral sclerosis: frequency and association with clinical features. Einstein (Sao Paulo) 2017;15:58–60.
   PubMedGoogle Scholar
• De Marchi F, Sarnelli MF, Solara V, Bersano E, Cantello R, Mazzini L. Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019;139:438–45.
   PubMed Web of Science ®Google Scholar
• van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JMA, van den Berg LH, Schröder CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health Qual Life Outcomes. 2016;14:107.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
   PubMed Web of Science ®Google Scholar
• Lillo P, Savage S, Mioshi E, Kiernan MC, Hodges JR. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler. 2012;13:102–9.
   PubMed Web of Science ®Google Scholar
• Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and behavioral manifestations in ALS: beyond motor system involvement. Diagn Basel Switz. 2021;11:624.
   PubMedGoogle Scholar
• Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, et al. The management of motor neurone disease. J Neurol Neurosurg Psychiatry. 2003;74 Suppl 4:iv32–iv47.
   PubMed Web of Science ®Google Scholar
• Benditt JO, Smith TS, Tonelli MR. Empowering the individual with ALS at the end-of-life: disease-specific advance care planning. Muscle Nerve 2001;24:1706–9.
   PubMed Web of Science ®Google Scholar
• Bede P, Oliver D, Stodart J, van den Berg L, Simmons Z, O Brannagáin D, et al. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry. 2011;82:413–8.
   PubMed Web of Science ®Google Scholar
• Heritier Barras AC, Adler D, Iancu Ferfoglia R, Ricou B, Gasche Y, Leuchter I, et al. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group. Swiss Med Wkly. 2013;143:w13830.
   PubMed Web of Science ®Google Scholar
• Kaub-Wittemer D, Steinbüchel Nv, Wasner M, Laier-Groeneveld G, Borasio GD. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26:890–6.
   PubMed Web of Science ®Google Scholar
• Hartmaier SL, Rhodes T, Cook SF, Schlusser C, Chen C, Han S, et al. Qualitative measures that assess functional disability and quality of life in ALS. Health Qual Life Outcomes. 2022;20:12.
   PubMed Web of Science ®Google Scholar
• Van Groenestijn AC, Schröder CD, Kruitwagen-Van Reenen ET, Van Den Berg LH, Visser-Meily JMA. Participation restrictions in ambulatory amyotrophic lateral sclerosis patients: physical and psychological factors. Muscle Nerve 2017;56:912–8.
   PubMed Web of Science ®Google Scholar
• Sandstedt P, Johansson S, Ytterberg C, Ingre C, Holmqvist LW, Kierkegaard M. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269–73.
   PubMed Web of Science ®Google Scholar
• Foley G, Timonen V, Hardiman O. Experience of services as a key outcome in amyotrophic lateral sclerosis (ALS) care: the case for a better understanding of patient experiences. Am J Hosp Palliat Care. 2012;29:362–7.
   PubMed Web of Science ®Google Scholar
• Kierkegaard M, Gottberg K, Johansson S, Littorin S, Sandstedt P, Ytterberg C, et al. Healthcare utilisation and satisfaction with care in patients with amyotrophic lateral sclerosis – an observational study. J Neuromuscul Dis. 2021;8:1079–88.
   PubMedGoogle Scholar
• Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-surveys (CHERRIES). J Med Internet Res. 2004;6:e34.
   PubMed Web of Science ®Google Scholar
• Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med. 1995;9:207–19.
   PubMed Web of Science ®Google Scholar
• Glasmacher SA, Wong C, Pearson IE, Pal S. Survival and prognostic factors in C9orf72 repeat expansion carriers: a systematic review and meta-analysis. JAMA Neurol. 2020;77:367–76.
   PubMed Web of Science ®Google Scholar
• Chiò A, Canosa A, Calvo A, Moglia C, Cicolin A, Mora G. Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis. Expert Rev Neurother. 2021;21:1419–40.
   PubMed Web of Science ®Google Scholar